---
title: "ARS Pharmaceuticals (SPRY.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SPRY.US/norm.md"
symbol: "SPRY.US"
name: "ARS Pharmaceuticals"
parent: "https://longbridge.com/en/quote/SPRY.US.md"
datetime: "2026-03-14T14:47:45.309Z"
locales:
  - [en](https://longbridge.com/en/quote/SPRY.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SPRY.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SPRY.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/SPRY.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/SPRY.US/norm.md)


# ARS Pharmaceuticals (SPRY.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.4194 | -0.5177 | -0.4563 | -0.3461 | 0.4205 |
| ROE | -126.22% | -120.36% | -85.23% | -55.89% | 87.26% |
| Revenue | 28.09M | 32.50M | 15.72M | 7.97M | 86.58M |
| Net income | -41.32M | -51.15M | -44.88M | -33.94M | 49.93M |
| Operating income | -41.47M | -53.19M | -47.61M | -37.18M | 47.20M |
| Gross margin | 65.83% | 66.33% | 42.62% | 49.25% | 95.50% |
| Net margin | -147.13% | -157.38% | -285.57% | -425.69% | 57.67% |
| Profit quality | - | - | - | - | 112.36% |

## Balance Sheet (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 327.65M | 372.80M | 313.47M | 327.32M | 351.15M |
| Leverage | 2.87 | 2.52 | 1.63 | 1.43 | 1.37 |
| BVPS | 1.15 | 1.49 | 1.95 | 2.33 | 2.62 |
| Turnover | 0.2483 | 0.4836 | 0.4196 | 0.3501 | 0.3051 |
| Cash & STI | 244.99M | 288.21M | 240.13M | 275.73M | 314.02M |
| Inv & Rec | 8.37M | 7.78M | 8.74M | 7.27M | 5.21M |
| LT assets | 2.46M | 2.65M | 2.64M | 1.15M | 1.07M |
| Net debt | -76.47M | -118.40M | -166.51M | -206.27M | -244.64M |

## Cash Flow Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -43.48M | -47.05M | -39.59M | -40.74M | 42.00M |
| Investing CF | 24.11M | -44.98M | 48.57M | 29.06M | -101.76M |
| Financing CF | 1.13M | 100.05M | 2.70M | 725000.00 | 70.92M |
| Free CF | -20.17M | -31.43M | -19.87M | -21.46M | 24.11M |
| OCF coverage | - | -23881.73% | -77631.37% | -44771.43% | 13908.61% |
| Repaid & issued | -1.49M | 97.75M | - | - | - |
| CapEx | 0.0000 | -197000.00 | -51000.00 | -91000.00 | -302000.00 |